BioSpace News Archive

Genetown

Mevion Launches “Mevion Capital” to Provide Customized Proton Therapy Funding Solutions for Healthcare Communities in US and Canada

Mevion Medical Systems, the leading global provider of compact proton therapy systems for use in radiation treatment for cancer patients, announces the launch of ‘Mevion Capital’ in the US and Canada.

October 1, 2023
·
2 min read
Pharm Country

Viatris Announces Agreements on Remaining Planned Divestitures; Upon Closing Would Achieve its Original Total Target of a Multiple Above 12x on 2022 Estimated Adjusted EBITDA

Viatris Inc. announced it has received an offer for the divestiture of substantially all of its Over-the-Counter business, and has entered into definitive agreements to divest its Women’s Healthcare business, its Active Pharmaceutical Ingredients business in India and commercialization rights in certain non-core markets that were acquired as part of the Upjohn Transaction.

October 1, 2023
·
20 min read
Policy

WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease

WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization, congratulates its strategic partner, Amicus Therapeutics, on receiving U.S. FDA’s approval for Pombiliti™ + Opfolda™ 65mg capsules.

October 1, 2023
·
4 min read